IL18

Interleukin-18 · Q14116 · IL18 on Sugi Atlas →

1,809 patent compounds predicted against IL18, 1,201 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL11054945 SCHEMBL11054945 0.79 1/20
SCHEMBL4113028 SCHEMBL4113028 0.71 1/20
SCHEMBL4113073 SCHEMBL4113073 0.71 1/20
SCHEMBL11645090 SCHEMBL11645090 0.71 1/20
SCHEMBL4111010 SCHEMBL4111010 0.69 1/20
SCHEMBL4121767 SCHEMBL4121767 0.69 1/20
SCHEMBL11056656 SCHEMBL11056656 0.69 1/20
SCHEMBL4118174 SCHEMBL4118174 0.68 1/20
SCHEMBL4116856 SCHEMBL4116856 0.67 1/20
SCHEMBL4929006 SCHEMBL4929006 0.67 1/20
SCHEMBL11054936 SCHEMBL11054936 0.67 1/20
SCHEMBL11896323 SCHEMBL11896323 0.67 1/20
SCHEMBL11643709 SCHEMBL11643709 0.66 1/20
SCHEMBL10822517 SCHEMBL10822517 0.64 1/20
SCHEMBL6125249 SCHEMBL6125249 0.64 1/20
SCHEMBL11896322 SCHEMBL11896322 0.63 1/20
SCHEMBL4104728 SCHEMBL4104728 0.61 1/20
SCHEMBL4118086 SCHEMBL4118086 0.61 1/20
SCHEMBL7248947 SCHEMBL7248947 0.61 1/20
SCHEMBL7041250 SCHEMBL7041250 0.61 1/20

Clinical trials — most relevant to IL18 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
The Effects of Fixed Space Maintainers Luting with Self-Adhesive Resin Cement on the Gingival Crevicular Fluid of Interleukin-18 Level PHASE4COMPLETED
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency As Open Label Extension PHASE3COMPLETED
Disulfiram in Rheumatoid Arthritis PHASE2NOT_YET_RECRUITING
Tadekinig Alfa (IL-18BP) Rescue Therapy for CAR T Cell Related Cytokine Release Syndrome (CRS) and HLH-like Syndrome EARLY_PHASE1RECRUITING
Adding Colchicine to Tocilizumab in Patients With Severe COVID-19 Pneumonia. EARLY_PHASE1UNKNOWN
Minimally Invasive Kidney Transplantation nanUNKNOWN
Role NLRP3 Inflammasome in Weight Loss Following Sleeve Gastrectomy in Morbidly Obese Patients nanUNKNOWN
Biomarker of Lung Injury in ARDS Patients Receiving ECMO Support nanUNKNOWN
Macrolide Mediates Pulmonary Infection of Pseudomonas Aeruginosa nanCOMPLETED
Corticosteroid Treatment for Acute Respiratory Distress Syndrome nanCOMPLETED
TRPM2 Gene Polymorphism, NLRP3 Inflammasome Expression in Vitiligo Patients nanACTIVE_NOT_RECRUITING
Effect of Periodontal Treatment on Inflammasome Proteins in Periodontal Diseases nanUNKNOWN
Caspase-1 Activity, IL-1beta, and IL-18 in Patients With FMF nanNOT_YET_RECRUITING
Inflammasomes in Cell Death in FTMH, ERM, and RRD nanCOMPLETED
IL-10, IL-12 and IL-18 Levels in the Gingival Crevicular Fluid of Patients With Periodontitis and Healthy Controls nanCOMPLETED
Potential Role of Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients: Impact of Ferretin and D -Dimer. nanUNKNOWN
Role of Type 2 Diabetes in Potentiating the Inflammatory Response Post Extracorporeal Circulation After Cardiac Surgery nanWITHDRAWN
Chromosomal and Morphological Structure of Mature and Immature Male Germ Cells and Recognition of IL-18 in Testicular Tissue of Azoospermic Men nanCOMPLETED
Tissue and Serum Level of NLRP1, NLRP3 and Il-18 in Early Stages of mf Patients nanUNKNOWN
Pigeon Peas (Cajanus Cajan) : a Natural Anti-inflammatory Facilitating Weight Loss in Obese Patients Returning to Sport? nanUNKNOWN
Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection nanUNKNOWN
Acupuncture for Reduction of Inflammation nanCOMPLETED
N/LP Ratio as Predictor of Mortality in Septic AKI Patients nanUNKNOWN
The Role Of Neutrophil Proteases As Global Regulators Of Il-1 Family Cytokine Activity In Skin Disorders nanUNKNOWN
The Value of Interleukin-1β and Interleukin-33 Genetic Expression in the Pathogenesis and Differentiation of Primary ITP and SLE-Related Thrombocytopenia nanNOT_YET_RECRUITING
Relation of IL23R and IL17A Gene Polymorphisms Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis Susceptibility and Activity nanNOT_YET_RECRUITING
Ankylosing Spondylitis nanNOT_YET_RECRUITING
Decoding the Inflammasome Influence on Treatment Response in Acute Myeloid Leukemia nanRECRUITING
Cytokine Status of Covid-19 Patients nanCOMPLETED
Evaluation of CCR6 Gene Expression and Circulating CCL20 Levels as Potential Biomarkers in Rheumatoid Arthritis nanNOT_YET_RECRUITING

Related proteins — ESM-2 sequence neighbours (a IL18 binder may also engage these)

ProteinNameSimilarity
Q9XSR0 1.000 Q9XSR0 →
Q5I931 1.000 Q5I931 →
Q9TU73 1.000 Q9TU73 →
Q95M33 1.000 Q95M33 →
Q3ZT29 1.000 Q3ZT29 →
P70380 1.000 P70380 →
P97636 1.000 P97636 →
O19073 1.000 O19073 →
Q8QFQ8 0.999 Q8QFQ8 →
Q9XSQ7 0.998 Q9XSQ7 →
Q2HZH0 0.971 Q2HZH0 →
P21621 0.969 P21621 →
Q6R2X3 0.968 Q6R2X3 →
Q6P5D8 0.968 Q6P5D8 →
Q9YGD3 0.968 Q9YGD3 →
Q28292 0.968 Q28292 →
Q6PUD2 0.966 Q6PUD2 →
P14628 0.966 P14628 →
P79162 0.966 P79162 →
Q28386 0.966 Q28386 →
P09428 0.966 P09428 →
P41687 0.966 P41687 →
Q2MH07 0.966 Q2MH07 →
Q8R460 0.965 Q8R460 →
P10749 0.965 P10749 →
SMCHD1 Structural maintenance of chromosomes flexible hinge domain-containing protein 1 0.964 landscape →
P79182 0.964 P79182 →
IL36G Interleukin-36 gamma 0.963 landscape →
IL1B Interleukin-1 beta 0.963 landscape →
Q9UHA7 0.963 Q9UHA7 →